focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Share News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Marlowe buys Santia; Gaming Realms notes new launch

Tue, 07th Sep 2021 14:59

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Marlowe PLC - London-based safety services and software provider - Acquires environmental safety testing and consultancy business Santia Ltd for a GBP4.5 million consideration. This includes GBP4.3 million initial payment and a deferred GBP200,000 to be paid pending the achievement of certain integration objectives. Plans to settle acquisition with its existing cash resources. Says the acquisition offers "attractive synergies" with its water and air hygiene platform, WCS Group. Notes that Santia produced adjusted earnings before interest, tax, depreciation and amortisation of GBP800,000 on revenue of GBP10.6 million in 2019.

----------

Gaming Realms PLC - London-based developer of mobile betting games - Launches content in Pennsylvania, US, after obtaining an Interactive Gaming Manufacturer Licence in the state. Takes its first Slingo game live in Pennsylvania with BetMGM, with more games to follow. Notes agreements with a number of operators, including Rush Street Interactive in Pennsylvania. Says the launch follows launches with operators in New Jersey and Michigan. Executive Chair Michael Buckley says: "We are delighted to be launching our Slingo Originals games in Pennsylvania, which is one of the three leading US states for iGaming and where gambling revenue increased over 60% year-on-year in July 2021."

----------

Avation PLC - passenger aircraft leasing company based in Singapore - Repays outstanding export credit agency insured loans associated with eight ATR 72 aircraft previously on lease to Virgin Australia Airlines. Says it repaid the loans with released deposits held by the export credit agencies and a new commercial bank financing package. Its financing package is backed by the leases of three ATR 72 aircraft to Heviliftm, the company notes. Executive Chair Jeff Chatfield adds: "The export credit loans associated with the Virgin Australian aircraft have now been refinanced and retired. It is pleasing that commercial bank aircraft lending appears to be reopening following the disruption caused by Covid-19".

----------

Chariot Ltd - Africa-focused transitional energy company - Agrees drilling rig contract with Stena Drilling. Plans to use the contractor's Stena Don drilling rig for the planned Anchois gas appraisal well in its Lixus licence, offshore Morocco. Expects drilling to begin in December and last for forty days.

----------

Arecor Therapeutics PLC - Saffron Walden, England-based biopharmaceutical company - Signs formulation agreement with Intas Pharmaceuticals Ltd to develop a differentiated product for Intas, who will fund the development work. Instas has the option to acquire the global rights and commercialise any products produced, the company notes. The product will be based on Arecor's proprietary formulation technology platform Arestat, which "enhances the properties of therapeutic proteins, peptides and vaccines...to deliver superior reformulations of existing products as well as improving properties of new products in development," the company says.

----------

Shearwater Group PLC - London-based cybersecurity provider - Sees group company Pentest Ltd secure a one-year contract renewal worth USD1 million. Under the renewed contract Pentest will continue to provide vulnerability assessment and penetration testing services to an unnamed global technology corporation, the company says. "Securing this major contract renewal, with Pentest again being selected as the preferred supplier for a global technology client, highlights the quality and depth of work being provided by companies within our group," adds Chief Executive Phil Higgins.

----------

Eqtec PLC - Cork, Ireland-based gasification and engineering company - Agrees to extend the option period with Rotunda Group Ltd and its subsidiary Shankley Biogas Ltd for the Southport Hybrid Energy Park project up to September 30. Says the extension was agreed after Covid-19 disruption prevented the parties from concluding the acquisition before the initial option period ended. Expects to take full ownership of the project from Rotunda through the acquisition of the project's special-purpose vehicle Shankley Biogas Ltd.

----------

Duke Royalty Ltd - royalty finance company - Provides a GBP2.2 million follow-on investment in IT-focused investment holding company InTec Business Solutions Ltd, which will fund its latest acquisition. Says InTec plans to acquire Cumbria-based a IT managed services company Miller Waite Ltd. Following this addition, the company's investment in InTec totals GBP9.9 million. Chief executive of Duke Royalty, Neil Johnson, says: "We are pleased to see that InTec's clearly defined strategy is off to a strong start, with Miller Waite adding additional product, profitability and diversification to the business. Miller Waite has a longstanding SME client base, which speaks to the quality of its offering."

----------

Blackbird PLC - London-based cloud video editing platform - Says a global broadcast company has licensed its core video technology, Blackbird, including its patented video codec technology, in a 5-year deal. Expects the contact value to total EUR2 million over the length of the contract. Chief Executive Ian McDonough says: "Under this first technology licensing contract, the [original equipment manufacturer] partner will use the core Blackbird video technology to provide the basis for their own advanced on premise and cloud native editing platform, extending its use into new product areas. They will sell the editing software as an integral part of their broadcast production suite to their customers around the world."

----------

United Oil & Gas PLC - AIM-listed oil & gas company with assets in Italy, UK, Jamaica and Egypt - Enters binding sale and purchase agreement with Quattro Energy Ltd to sell its UK Central North Sea Licences, P2480 and P2519, for a GBP3.2 million headline consideration. Says the deal includes an initial cash payment of GBP2 million upon completion. Expects an additional uplift amount of GBP1.2 million once the field development plan for block 15/18e is approved.

----------

Open Orphan PLC - London-based pharmaceutical services company - Notes positive result in its RSV Human Challenge Study conducted by its subsidiary hVIVO. Says the Phase 2 double-blinded, placebo controlled trial was testing Barvarian Nordic AS's respiratory syncytial virus vaccine candidate, MVA-BN RSV. Adds that the study of 51 healthy adult volunteers indicated a "significant reduction in viral load in vaccinated subjects" when compared to those given a placebo. Respiratory syncytial virus affects the respiratory tract of children and at-risk older adults, the company says. "With the global infectious disease market expected to reach a value of USD250 billion by 2025, we are already seeing a huge increase in interest across the entire pharmaceutical and biotech space in these previously underserved infectious disease areas. We look forward to offering our industry leading services to help novel therapeutics and vaccines progress through clinical development," adds Executive Chair Cathal Friel.

----------

By Scarlett Butler; scarlettbutler@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
14 Dec 2020 11:38

Open Orphan upbeat on progress with nasal Covid-19 vaccine

(Sharecast News) - Specialist pharmaceuticals contract research organisation Open Orphan announced on Monday that the first in-human study of the Codagenix intranasal SARS-CoV-2 vaccine candidate for Covid-19 had gained approval from the UK's Medicines and Healthcare Products Regulatory Agency (MHRA).

Read more
24 Nov 2020 16:27

UK EXECUTIVE CHANGE SUMMARY: Ocean Wilson Long-Time Finance Head Exits

UK EXECUTIVE CHANGE SUMMARY: Ocean Wilson Long-Time Finance Head Exits

Read more
19 Nov 2020 21:18

IN BRIEF: Open Orphan To Lead Challenge Agent Development Consortium

IN BRIEF: Open Orphan To Lead Challenge Agent Development Consortium

Read more
5 Nov 2020 16:32

IN BRIEF: Open Orphan Wins GBP2.5 Million Contract For Influenza Study

IN BRIEF: Open Orphan Wins GBP2.5 Million Contract For Influenza Study

Read more
30 Oct 2020 11:30

Open Orphan secures new two-year contract with German client

(Sharecast News) - Pharmaceutical services company Open Orphan announced a new two-year contract with an unnamed tier 1 Germany-based pharmaceutical company on Friday.

Read more
30 Oct 2020 11:07

Open Orphan Inks Two-Year Contract With Tier 1 German Pharma Company

Open Orphan Inks Two-Year Contract With Tier 1 German Pharma Company

Read more
20 Oct 2020 15:59

IN BRIEF: Open Orphan To Develop Covid Study Model For UK Government

IN BRIEF: Open Orphan To Develop Covid Study Model For UK Government

Read more
20 Oct 2020 09:49

Open Orphan to assist UK govt in Covid-19 study

(Sharecast News) - Pharmaceutical services company Open Orphan has signed a contract with the UK Government that will see the firm assist in the development of a Covid-19 human challenge study model to safely speed up the development of an efficacious vaccine.

Read more
16 Oct 2020 15:24

IN BRIEF: Open Orphan In Talks With UK Government Over Corona Study

IN BRIEF: Open Orphan In Talks With UK Government Over Corona Study

Read more
16 Oct 2020 08:57

Open Orphan continues talks over coronavirus challenge study

(Sharecast News) - Open Orphan updated the market on its talks with the UK government and other partners for a coronavirus challenge study in the UK on Friday, confirming that "advanced negotiations" were ongoing.

Read more
30 Sep 2020 18:37

UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise

UK EARNINGS SUMMARY: Itaconix 2019 Loss Narrows On Strong Revenue Rise

Read more
28 Sep 2020 19:34

IN BRIEF: Open Orphan Wins GBP4.3 Million Human Viral Study Contract

IN BRIEF: Open Orphan Wins GBP4.3 Million Human Viral Study Contract

Read more
24 Sep 2020 17:35

UK TRADING UPDATE SUMMARY: Personal Group Lauds Royal Mail Contract

UK TRADING UPDATE SUMMARY: Personal Group Lauds Royal Mail Contract

Read more
22 Sep 2020 19:35

IN BRIEF: Open Orphan Lauds Venn's Clinical Study Support Contract Win

IN BRIEF: Open Orphan Lauds Venn's Clinical Study Support Contract Win

Read more
22 Sep 2020 09:43

Open Orphan subsidiary wins 'important' new contract

(Sharecast News) - Pharmaceutical contract research organisation Open Orphan secured an "important" new contract to support an unnamed European client via its French subsidiary, Venn Life Sciences.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.